Reductions in Fecal Calprotectin and Lactoferrin Following Ustekinumab Induction Therapy in Patients With Moderate to Severe Crohn's Disease Who Have Previously Failed or Been Intolerant of TNF Antagonist Therapies
2011
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI